Christopher Wright
Directeur/Membre du Conseil chez ALKERMES PLC
Fortune : 228 782 $ au 31/05/2024
Postes actifs de Christopher Wright
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALKERMES PLC | Directeur/Membre du Conseil | 24/05/2022 | - |
| Independent Dir/Board Member | 24/05/2022 | - | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Christopher Wright
Anciens postes connus de Christopher Wright
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - | 26/03/2021 |
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Directeur Technique/Scientifique/R&D | - | - |
| Harvard Medical School | Corporate Officer/Principal | - | - |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2017 | - |
| AXCA HEALPAR | Directeur Technique/Scientifique/R&D | - | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - | - |
Formation de Christopher Wright
| Harvard University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
| Vrije Universiteit Amsterdam | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 9 |
| Pays-Bas | 2 |
| Irlande | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Sectorielle
| Health Technology | 8 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| AXCA HEALPAR | Health Technology |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| ALKERMES PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Health Technology |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Christopher Wright
- Expérience
